A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the first part of this study is to determine the safety and tolerability of
ascending doses of valproic acid (also known as Depacon) administered as intravenous infusion
(IV) in doses ranging from 15 mg/kg to 250 mg/kg in healthy subjects.
The second part of the study will also be to determine the safety and tolerability of single
ascending doses of valproic acid administered as IV in trauma subjects with hemorrhagic
shock.